Surface Oncology, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q2 2023.

Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
02 Aug 2023

Quick Takeaways

  • Surface Oncology, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q2 2023.
  • Headline metric: Return On Equity -106%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+130%</span>.
  • Most recent SEC facts end date: 31 Jul 2023.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2023-07-31) highlights Return On Equity -105.8%, Return On Assets -71.2%, and Current Ratio 3.6x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

21.9/100

Weak Confidence medium

Return On Equity

-106%

Metric score 0.0/100

Return On Assets

-71%

Metric score 0.0/100

Financial Health

Current Ratio
3.6x
Debt to Equity
0.64x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Revenues YoY

Key metrics snapshot

Return On Equity

-106%

YoY: +130%

Industry median: -47% (n=218)

View history

Return On Assets

-71%

YoY: +126%

Industry median: -44% (n=217)

View history

Current Ratio

3.6x

YoY: -56%

Industry median: 3.67x (n=218)

View history

Debt-to-equity

0.64x

YoY: +25%

Industry median: 0.31x (n=169)

View history

Revenues YoY

-100%

YoY:

Industry median: 11% (n=96)

View history

NetIncomeLoss YoY

-47%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -106% +130%
Return On Assets -71% +126%

Financial Health

Metric Latest value YoY change
Current Ratio 3.6x -56%
Debt-to-equity 0.64x +25%

Growth

Metric Latest value YoY change
Revenues YoY -100%
NetIncomeLoss YoY -47%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 60,824,474 +4.8%
Common Stock, Shares, Outstanding 60,730,274 +9.7%
Common Stock, Value, Issued $6,000 0%
Weighted Average Number of Shares Outstanding, Basic 60,717,899 +11%
Weighted Average Number of Shares Outstanding, Diluted 60,717,899 +11%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $0 -100%
Research and Development Expense $59,789,000 -8.3%
General and Administrative Expense $26,362,000 +1.3%
Operating Income (Loss) $89,385,000 -47%
Income Tax Expense (Benefit) $0
Earnings Per Share, Basic -2 -24%
Earnings Per Share, Diluted -2 -24%
Cash and Cash Equivalents, at Carrying Value $14,842,000 -80%
Assets, Current $60,588,000 -62%
Property, Plant and Equipment, Net $2,499,000 -52%
Operating Lease, Right-of-Use Asset $2,919,000 -89%
Other Assets, Noncurrent $0 -100%
Assets $66,006,000 -66%
Accounts Payable, Current $609,000 +25%
Liabilities, Current $16,828,000 -15%
Operating Lease, Liability, Noncurrent $0 -100%
Liabilities $16,828,000 -75%
Accumulated Other Comprehensive Income (Loss), Net of Tax $221,000 +81%
Retained Earnings (Accumulated Deficit) $252,262,000 -58%
Stockholders' Equity Attributable to Parent $49,178,000 -61%
Liabilities and Equity $66,006,000 -66%
Common Stock, Shares Authorized 150,000,000 0%
Common Stock, Shares, Issued 60,730,274 +9.7%
Common Stock, Par or Stated Value Per Share 0 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $91,556,000 -43%
Operating Lease, Liability, Current $9,488,000 +66%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 5,000,000 0%
Preferred Stock, Shares Outstanding 0
Share-based Payment Arrangement, Expense $6,117,000 -22%
Interest Expense $5,771,000 +129%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY